Engaging key stakeholders, including clinical staff, families, communities, parent support groups, regulators and ethics experts, is crucial for the success of trials with novel or complex designs, especially those targeting a very vulnerable population like newborns with sepsis.
In this video, Dr. Maxensia Owor and Dr. Damalie Nalwanga, from Makerere University – Johns Hopkins University Research Collaboration, explain how the SNIP-AFRICA project is engaging a wide range of stakeholders to increase the effectiveness and impact of clinical studies on the management of neonatal sepsis in Africa.
Viewing this video requires cookie consent. Please accept cookies to proceed.
